Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Search results for

There are 22,198 results that match your search.22,198 results
  • In the first decision, the Austrian Supreme Patent and Trade Mark Senate (ASPTS) has found that in a declaratory action concerning the non-infringement of a patent the existing right (patent) as defined in the register shall form the basis of the proceedings. Thus, only the subject matter in dispute shall be compared with the subject matter of the patent. However, the validity of the claims of the patent on which the action is based shall not be the object of these declaratory proceedings.
  • Last January, the Chilean Congress approved a bill establishing the National Institute of Industrial Property (INAPI). The draft law was sent to the Congress in 2000 on the initiative of the President, and aims to create a new autonomous agency in charge of the records and administration of industrial property in Chile, with a legal personality and its own assets. It is linked to the President of the Republic through the Ministry of the Economy. The chief of this entity will be a National Director, appointed directly by the President.
  • A monthly column devoted to IP curiosities and controversies, named in honour of John of Utynam - who received the world's first recorded patent in 1449
  • Magali Touroude of Cabinet Plasseraud reveals a revolution in French IP legislation
  • Music buyers in the UK will soon pay less to download music from Apple's iTunes store after the US company said it would standardize music prices across Europe
  • Biedermann Motech and its licensee DePuy Spine won a patent infringement case in one of the first decisions to apply the US Supreme Court's directives in KSR v Teleflex
  • Leading patent firms in Egypt, Israel, Jordan, Lebanon, Nigeria, Saudi Arabia, South Africa and UAE
  • Lionel Vial, Béatrice Holtz and Alain Colombet of Lavoix outline the problems gene patenting is experiencing in French legislation
  • Dutch biotechnology company Crucell signed a licence agreement with Korean-based ISU ABXIS over STAR, a technology used for the production of recombinant human antibodies and proteins. This deal covers the research and development of the technology and includes an option for a commercial licence.